Skip to main content
. 2020 Jun;12(6):3178–3187. doi: 10.21037/jtd-19-3802

Table 1. Characteristics of the included studies.

Study Country Tumor diameter Pathology Imaging features Study design Number of participants Propensity score match Covariates in PSM analysis Multivariate analysis Covariates in adjusted model
Lob Seg
Okada 2001 Japan ≤2 cm NSCLC Undefined Retrospective cohort 139 70 No No
Yamato 2008 Japan ≤2 cm Adenocarcinoma Undefined Retrospective cohort 277 153 No Yes Age, sex, pT status, pN status, Noguchi classification
Zhong 2012 China ≤2 cm NSCLC Undefined Retrospective cohort 81 39 No Yes Age, sex, tumor size, histology, location
Tsutani 2013 Japan ≤3 cm Adenocarcinoma Undefined Retrospective cohort 81 81 Yes Age, sex, sold tumor diameter, SUVmax, side, and lobe No
Okada 2014 Japan ≤3 cm Adenocarcinoma Undefined Retrospective cohort 479 155 No Yes Age, sex, tumor diameter, SUVmax
Jiang 2014 China ≤1 cm NSCLC Undefined Retrospective cohort 71 19 No Yes Age, comorbidities, tumor diameter, serum CEA, pN status, differentiation, Visceral pleural involvement
Ogawa 2015 Japan 2–3 cm NSCLC Undefined Retrospective cohort 147 31 No - No -
Khullar 2015 USA ≤2 cm NSCLC Undefined Retrospective cohort 4857 286 No - Yes Age, sex, pathology, insurance, income, Charlson/Deyo score, differentiation, tumor diameter
Kodama 2016 Japan ≤2 cm NSCLC Non-GGN Retrospective cohort 232 80 Yes Age, sex, tumor diameter, CT feature, GGN ratio, preoperative diagnosis Yes CT feature, histology, lymphatic invasion, vascular invasion
Nishio 2016 Japan ≤2 cm NSCLC Undefined Retrospective cohort 72 118 Yes Age, sex, tumor diameter, GGN ratio, location Yes Age, tumor diameter, GGN ratio, location
Koike 2016 Japan ≤2 cm NSCLC Pure solid Retrospective cohort 151 100 Yes Age, sex, smoking status, percent predicted VC, FEV1/FVC, Serum CEA, tumor diameter, histology, lymphadenectomy extent, number of node examined Yes Age, smoking status, FEV1/FVC, serum CEA
Hattori 2017 Japan ≤2 cm NSCLC Non-GGN Retrospective cohort 270 83 No No

Lob, lobectomy; Seg, segmentectomy; PSM, propensity score match; SUV, standard uptake volume; GGN, ground glass nodule; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; NSCLC, non-small cell lung cancer.